Medicare to Cover Wegovy and Zepbound in July for $50 a Month, Cost Estimate Still Unknown
**Medicare’s Coverage of Obesity Drugs Begins in July, Cost Estimate Still Undisclosed**
Starting in July, Medicare will cover Wegovy and Zepbound for older adults, making these weight-loss drugs available for approximately $50 a month. However, the agency has not yet released an estimate of the total cost to taxpayers for this new coverage.
The introduction of this coverage marks a significant expansion in Medicare benefits, potentially providing affordable access to these medications for many older adults. Despite the impending start date, the financial implications of this program remain unclear, as the agency has not shared details regarding the projected overall expense.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 1, 2026







